Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA -3.03% inched 0.37% higher to $283.40 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -2.28% rising 0.64% to 15,786.99 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.19% rising 0.10% to 35,754.75. This was the stock's second consecutive day of gains. Moderna Inc. closed $214.09 below its 52-week high ($497.49), which the company reached on August 10th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.70% rose 0.30% to $121.87, Amgen Inc. /zigman2/quotes/209157011/composite AMGN -0.46% rose 1.05% to $213.53, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +1.54% rose 0.68% to $55.13. Trading volume (7.1 M) remained 6.2 million below its 50-day average volume of 13.3 M.